顽固性高血压：诊断，评估和治疗。
Resistant hypertension: diagnosis, evaluation, and treatment.
目的探索糖尿病肾病合并顽固性高血压联合降压的优化方案。
Objective to investigate the perfected antihypertensive treatment of diabetic nephropathy complicated with refractory hypertension.
在年老、肥胖、久坐的糖尿病人群中，有许多顽固性高血压需要采用新的治疗方法。
In an older, fatter, sedentary population with diabetes there is a lot more resistant hypertension and a need for new therapies.
顽固性高血压在临床实践中越来越多见但研究资料有限，其诊断需要良好的血压监测技术。
Resistant hypertension is a common disease in clinical practice but studies of resistant hypertension are limited.
在该研究中值得注意的是，已被确定为顽固性高血压的患者中约37%的被发现为假性顽固性。
Of note in that study, approximately 37% of patients who had been defined as resistant hypertension were found to have pseudo-resistance.
因为很多时候其测定是基于诊室的血压检测，白大衣效应或假性顽固性高血压的情况的存在情况也未得到确定。
A lot of the time, it is because the measurements were office-based blood pressure measurements and the presence of a significant white-coat effect or pseudo-resistance was not measured.
结论：缬沙坦、卡托普利缓释片是治疗高血压的有效药物，二者联合应用是治疗尿毒症顽固性高血压的较好方法。
Conclusion: Both captopril sustained-release tablets and valsartan are effective, and the combining use of the two drugs is effective on refractory hypertension in uremia patients.
方法对36例糖尿病肾病合并顽固性高血压患者随机分为治疗组和对照组，观察两组治疗前后降压情况、副作用和实验证据变化。
Methods There 36 diabetic nephropathy patients complicated with refractory hypertension were treated with two different therapies and the results were observed before and after the treatment.
方法对36例糖尿病肾病合并顽固性高血压患者随机分为治疗组和对照组，观察两组治疗前后降压情况、副作用和实验证据变化。
Methods There 36 diabetic nephropathy patients complicated with refractory hypertension were treated with two different therapies and the results were observed before and after the treatment.
应用推荐